Bioventix(GB:BVXP)
GBXÂ 1,950.000.00 (0.00%)
GB:BVXP
Bioventix financials statements
GBXÂ 1,950.00
At close:0.00 (0.00%)
Want to see GB:BVXP full AI Analyst Report?
Bioventix (BVXP) Ratios
17 Followers
Bioventix Ratios
GB:BVXP's free cash flow for Q4 2025 was £3.62M. For the 2025 fiscal year, GB:BVXP's free cash flow was decreased by £-38.85K and operating cash flow was £3.66M. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.53 | 9.17 | 7.42 | 10.08 | 9.43 |
| Quick Ratio | 8.02 | 8.65 | 7.07 | 9.61 | 9.07 |
| Cash Ratio | 3.75 | 3.87 | 3.47 | 4.76 | 4.89 |
| Solvency Ratio | 5.44 | 5.85 | 4.75 | 6.98 | 6.03 |
| Operating Cash Flow Ratio | 5.76 | 5.36 | 4.83 | 6.59 | 6.04 |
| Short-Term Operating Cash Flow Coverage | 2121.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | £ 10.56M | £ 10.72M | £ 11.10M | £ 10.88M | £ 10.52M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.12 | 1.11 | 1.14 | 1.10 | 1.11 |
| Debt Service Coverage Ratio | 1888.09 | 0.00 | 0.00 | 0.00 | 25801.47 |
| Interest Coverage Ratio | 69524.24 | 0.00 | 0.00 | 0.00 | 30605.69 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.54 | -0.50 | -0.56 | -0.56 | -0.65 |
| Profitability Margins | |||||
| Gross Profit Margin | 91.01% | 90.86% | 93.20% | 92.53% | 92.71% |
| EBIT Margin | 75.04% | 76.80% | 78.10% | 78.57% | 79.17% |
| EBITDA Margin | 75.47% | 77.51% | 78.93% | 79.58% | 80.40% |
| Operating Profit Margin | 75.04% | 75.51% | 77.88% | 78.38% | 79.13% |
| Pretax Profit Margin | 76.60% | 76.97% | 77.71% | 78.88% | 78.98% |
| Net Profit Margin | 58.70% | 57.83% | 59.51% | 65.33% | 65.48% |
| Continuous Operations Profit Margin | 58.70% | 57.83% | 59.51% | 65.33% | 65.48% |
| Net Income Per EBT | 76.64% | 75.12% | 76.57% | 82.82% | 82.91% |
| EBT Per EBIT | 102.08% | 101.94% | 99.78% | 100.64% | 99.81% |
| Return on Assets (ROA) | 59.36% | 58.96% | 58.97% | 63.04% | 58.50% |
| Return on Equity (ROE) | 66.70% | 65.66% | 67.46% | 69.40% | 64.92% |
| Return on Capital Employed (ROCE) | 85.21% | 85.73% | 88.29% | 83.14% | 78.16% |
| Return on Invested Capital (ROIC) | 65.28% | 64.41% | 67.61% | 68.85% | 64.61% |
| Return on Tangible Assets | 59.36% | 58.96% | 58.97% | 63.04% | 58.50% |
| Earnings Yield | 8.83% | 5.28% | 3.55% | 4.17% | 4.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.17 | 2.10 | 2.19 | 2.20 | 2.24 |
| Payables Turnover | 4.30 | 15.38 | 5.44 | 12.32 | 5.43 |
| Inventory Turnover | 1.65 | 1.74 | 1.50 | 1.69 | 1.85 |
| Fixed Asset Turnover | 30.17 | 32.44 | 28.47 | 22.26 | 16.88 |
| Asset Turnover | 1.01 | 1.02 | 0.99 | 0.96 | 0.89 |
| Working Capital Turnover Ratio | 1.22 | 1.20 | 1.24 | 1.19 | 1.12 |
| Cash Conversion Cycle | 304.78 | 359.91 | 342.21 | 351.46 | 292.91 |
| Days of Sales Outstanding | 168.31 | 173.75 | 166.57 | 165.60 | 162.73 |
| Days of Inventory Outstanding | 221.29 | 209.89 | 242.67 | 215.49 | 197.42 |
| Days of Payables Outstanding | 84.82 | 23.73 | 67.04 | 29.62 | 67.23 |
| Operating Cycle | 389.60 | 383.64 | 409.24 | 381.09 | 360.14 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.55 | 1.35 | 1.60 | 1.52 | 1.45 |
| Free Cash Flow Per Share | 1.54 | 1.34 | 1.60 | 1.51 | 1.45 |
| Dividend Paid and CapEx Coverage Ratio | 1.02 | 0.86 | 1.01 | 0.93 | 0.95 |
| Capital Expenditure Coverage Ratio | 113.05 | 366.45 | 524.56 | 746.81 | 643.21 |
| Operating Cash Flow Coverage Ratio | 737.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.62 | 0.54 | 0.61 | 0.62 | 0.65 |
| Free Cash Flow Yield | 9.31% | 4.88% | 3.65% | 3.93% | 4.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 11.30 | 18.97 | 28.20 | 23.97 | 23.42 |
| Price-to-Sales (P/S) Ratio | 6.65 | 10.95 | 16.78 | 15.66 | 15.34 |
| Price-to-Book (P/B) Ratio | 7.55 | 12.43 | 19.03 | 16.63 | 15.20 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.75 | 20.47 | 27.42 | 25.42 | 23.80 |
| Price-to-Operating Cash Flow Ratio | 10.65 | 20.42 | 27.37 | 25.39 | 23.77 |
| Price-to-Earnings Growth (PEG) Ratio | 16.39 | -2.94 | -7.57 | 2.52 | 1.68 |
| Enterprise Value Multiple | 8.27 | 13.62 | 20.70 | 19.11 | 18.42 |
| Enterprise Value | 80.96M | 138.49M | 222.36M | 194.95M | 173.59M |
| EV to EBITDA | 8.27 | 13.62 | 20.70 | 19.11 | 18.42 |
| EV to Sales | 6.24 | 10.56 | 16.34 | 15.21 | 14.81 |
| EV to Free Cash Flow | 10.09 | 19.75 | 26.70 | 24.70 | 22.99 |
| EV to Operating Cash Flow | 10.00 | 19.70 | 26.65 | 24.67 | 22.96 |
| Tangible Book Value Per Share | 2.18 | 2.21 | 2.30 | 2.31 | 2.27 |
| Shareholders’ Equity Per Share | 2.18 | 2.21 | 2.30 | 2.31 | 2.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.25 | 0.23 | 0.17 | 0.17 |
| Revenue Per Share | 2.48 | 2.51 | 2.61 | 2.46 | 2.25 |
| Net Income Per Share | 1.46 | 1.45 | 1.55 | 1.61 | 1.47 |
| Tax Burden | 0.77 | 0.75 | 0.77 | 0.83 | 0.83 |
| Interest Burden | 1.02 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.11 | 0.11 | 0.07 | 0.09 | 0.08 |
| SG&A to Revenue | 0.05 | 0.16 | 0.15 | 0.14 | 0.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.01 | 0.02 |
| Income Quality | 1.06 | 0.93 | 1.03 | 0.94 | 0.99 |
Currency in GBP

